“…Even though the IRE1/XBP1s axis is well-recognized to contribute to innate immune responses upon PRR engagement, most of these studies emerged from work in macrophages and DC subsets that do not belong to the cDC1 lineage [ 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 ]. Reports on activated cDC1s include parasite infection [ 29 ], and we reported that human/mouse cDC1s use IRE1 for optimal proinflammatory cytokine production using pharmacological IRE1 inhibitors [ 10 , 14 ]. To extend these findings and identify efficient IRE1 activators in differentiated cDC1s, we stimulated OP9-DL1 cDCs from ERAI mice with agonists of major families of PRRs: LPS (TLR4 agonist), Poly(I:C) (TLR3 agonist), Curdlan (Dectin-1 agonist), DMXAA (STING agonist), MDP (NOD2 agonist), and CpG (TLR9 agonist).…”